9.8 0.01 (0.1%) | 07-14 16:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 12.25 | 1-year : | 13.46 |
Resists | First : | 10.49 | Second : | 11.52 |
Pivot price | 10.22 | |||
Supports | First : | 8.81 | Second : | 7.32 |
MAs | MA(5) : | 10.13 | MA(20) : | 10.24 |
MA(100) : | 10.17 | MA(250) : | 9.97 | |
MACD | MACD : | -0.1 | Signal : | -0.1 |
%K %D | K(14,3) : | 31.6 | D(3) : | 37.7 |
RSI | RSI(14): 39.3 | |||
52-week | High : | 11.82 | Low : | 8.81 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ ALPA ] has closed above bottom band by 12.2%. Bollinger Bands are 877.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 7 days. This is a sign that the current trend might continue.
If tomorrow: | Open lower | Open higher |
High: | 9.91 - 9.97 | 9.97 - 10.03 |
Low: | 8.68 - 8.75 | 8.75 - 8.81 |
Close: | 9.69 - 9.8 | 9.8 - 9.9 |
Alpha Healthcare Acquisition Corp. III does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses or entities. It focuses to source, acquire, and manage a business in the healthcare industry in the United States. The company was incorporated in 2021 and is based in New York, New York.
Wed, 26 Jul 2023
Top Five Stock Market Losers of 26/07/23: EEFT, CTCX, MXL, SNAP, SPWR - CoinChapter
Thu, 05 Jan 2023
Pittsburgh's Carmell Therapeutics is going public via SPAC - Technical.ly
Thu, 05 Jan 2023
ALPA executes merger agreement with Carmell Therapeutics - Pharmaceutical Technology
Thu, 05 Jan 2023
Carmell Therapeutics to go public via Alpha Healthcare (NASDAQ:ALPA) - Seeking Alpha
Wed, 04 Jan 2023
Alpha Healthcare Acquisition Corp. III Announces Merger with Carmell Therapeutics, a Phase 2 Stage Biotechnology ... - Business Wire
Tue, 08 Feb 2022
SPAC Market Struggling to Find Footing - Boardroom Alpha - TheStreet
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
NASDAQ
|
|
Sector:
Financial Services
|
|
Industry:
Shell Companies
|
|
Shares Out | 16 (M) |
Shares Float | 11 (M) |
Held by Insiders | 2.9 (%) |
Held by Institutions | 81.2 (%) |
Shares Short | 4 (K) |
Shares Short P.Month | 4 (K) |
EPS | 0.15 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | -0.08 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | -0.8 % |
Return on Equity (ttm) | 0 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | -1 (M) |
Levered Free Cash Flow | 1 (M) |
PE Ratio | 61.25 |
PEG Ratio | 0 |
Price to Book value | -140 |
Price to Sales | 0 |
Price to Cash Flow | -306.57 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |